Listerine Sensitivity Tops J&J Innovation Pipeline In '18
This article was originally published in The Pink Sheet & The Rose Sheet
Johnson & Johnson will launch a Listerine mouthwash incorporating a class II device to address tooth sensitivity, Chief Technology Officer John Ghaim said during J&J’s Medical Devices & Consumer Analyst Day May 16. The company plans to launch 150 new products globally in 2018, which should help the company achieve sales ahead of the consumer health category.
You may also be interested in...
When J&J CEO Gorsky says, "We're not just sitting back, we're making aggressive moves in areas such as e-commerce, investments in that shift," his words are music to analysts' ears. J&J has OTC drug and other consumer health brands to drive growth, but it's missing the digital piece, they say.
J&J is growing Listerine mouthwash sales tapping into local tastes while continuing a global marketing push, says consumer business chief Jorge Mesquita. The firm also is developing strategy to make its brands “ambidextrous,” competing among small as well as large businesses.
"Some much weaker markets and some macroeconomic conditions, particularly in China and India" prompt J&J to adjusts its overall and consumer business expectations, CFO Dominic Caruso says. Its consumer product revenues climbed 1.7% to $3.5bn in is latest quarter.